Manganese chloride stimulates rat microglia to release hydrogen peroxide

Toxicology Letters

Volumn 173, Issue 2, 2007, Pages 88-100

  Zhang, Ping ^a   Hatter, Angela ^a   Liu, Bin ^a,b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Dopamine neuron; Microglia; Parkinsonism; Reactive oxygen species

Indexed keywords

HYDROGEN PEROXIDE; MANGANESE CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; MICROGLIA; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTHRACENES; BUTADIENES; CELL LINE; CELLS, CULTURED; CHLORIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYDROGEN PEROXIDE; IMIDAZOLES; MANGANESE COMPOUNDS; MICROGLIA; NADPH OXIDASE; NITRILES; ONIUM COMPOUNDS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RATS; RATS, INBRED F344; TIME FACTORS;

RATTUS;

EID: 34548415358     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.06.013     Document Type: Article

References (62)

1. Aschner M., Gannon M., and Kimelberg H.K. Manganese uptake and efflux in cultured rat astrocytes. J. Neurochem. 58 (1992) 730-735
2. Aschner M., Erikson K.M., and Dorman D.C. Manganese dosimetry: species differences and implications for neurotoxicity. Crit. Rev. Toxicol. 35 (2005) 1-32
3. Autissier N., Rochette L., Dumas P., Beley A., Loireau A., and Bralet J. Dopamine and norepinephrine turnover in various regions of the rat brain after chronic manganese chloride administration. Toxicology 24 (1982) 175-182
4. Babior B.M. NADPH oxidase. Curr. Opin. Immunol. 16 (2004) 42-47
5. Barbeau A. Manganese and extrapyramidal disorders. Neurotoxicology 5 (1984) 13-35
6. Benard G., Bellance N., James D., Parrone P., Fernandez H., Letellier T., and Rossignol R. Mitochondrial bioenergetics and structural network organization. J. Cell Sci. 120 (2007) 838-848
7. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13681-13686
8. Bird E.D., Anton A.H., and Bullock B. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 5 (1984) 59-65
9. Bonilla E., and Prasad A.L. Effects of chronic manganese intake on the levels of biogenic amines in rat brain regions. Neurobehav. Toxicol. Teratol. 6 (1984) 341-344
10. Brookes P.S. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radical Biol. Med. 38 (2005) 12-23
11. Carvey P.M., Punati A., and Newman M.B. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Cell Transplant. 15 (2006) 239-250
12. Cheepsunthorn P., Radov L., Menzies S., Reid J., and Connor J.R. Characterization of a novel brainderived microglial cell line isolated from neonatal rat brain. Glia 35 (2001) 53-62
13. Cuschieri J., and Maier R.V. Mitogen-activated protein kinase (MAPK). Crit. Care Med. 33 (2005) 417-419
14. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
15. Desole M.S., Esposito G., Migheli R., Sircana S., Delogu M.R., Fresu L., Miele M., de Natale G., and Miele E. Glutathione deficiency potentiates manganese toxicity in rat striatum and brainstem and in PC12 cells. Pharmacol. Res. 36 (1997) 285-292
16. Donaldson J., LaBella F.S., and Gesser D. Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology 2 (1981) 53-56
17. Donaldson J., McGregor D., and LaBella F. Manganese neurotoxicity: a model for free radical mediated neurodegeneration?. Can. J. Physiol. Pharmacol. 60 (1982) 1398-1405
18. Dringen R., Kussmaul L., and Hamprecht B. Rapid clearance of tertiary butyl hydroperoxide by cultured astroglial cells via oxidation of glutathione. Glia 23 (1998) 139-145
19. Dukhande V.V., Malthankar-Phatak G.H., Hugus J.J., Daniels C.K., and Lai J.C. Manganese-induced neurotoxicity is differentially enhanced by glutathione depletion in astrocytoma and neuroblastoma cells. Neurochem. Res. 31 (2006) 1349-1345
20. Emre Y., Hurtaud C., Nubel T., Criscuolo F., Ricquier D., and Cassard-Doulcier A.M. Mitochondria contribute to LPS-induced MAPK activation via uncoupling protein UCP2 in macrophages. Biochem. J. 402 (2007) 271-278
21. Eriksson H., Magiste K., Plantin L.O., Fonnum F., Hedstrom K.G., Theodorsson-Norheim E., Kristensson K., Stalberg E., and Heilbronn E. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch. Toxicol. 61 (1987) 46-52
22. Facchinetti F., Dawson V.L., and Dawson T.M. Free radicals as mediators of neuronal injury. Cell Mol. Neurobiol. 18 (1998) 667-682
23. Farina C., Aloisi F., and Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28 (2006) 138-145
24. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 18623-18632
25. Fujiyama J., Hirayama K., and Yasutake A. Mechanism of methylmercury efflux from cultured astrocytes. Biochem. Pharmacol. 47 (1994) 1525-1530
26. 2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol. Appl. Pharmacol. 115 (1992) 1-5
27. Gavin C.E., Gunter K.K., and Gunter T.E. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 20 (1999) 445-453
28. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., and Richardson R.J. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 48 (1997) 650-658
29. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., and Richardson R.J. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20 (1999) 239-247
30. Greenamyre J.T., MacKenzie G., Peng T.I., and Stephans S.E. Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 66 (1999) 85-97
31. HaMai D., and Bondy S.C. Oxidative basis of manganese neurotoxicity. Ann. N.Y. Acad. Sci. 1012 (2004) 129-141
32. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., and Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275 (1997) 1649-1652
33. Jezek P., and Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell Biol. 37 (2005) 2478-2503
34. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
35. Kidd P.M. Parkinson's disease as multi-factorial oxidative neurodegeneration: implications for integrative management. Altern. Med. Rev. 5 (2000) 502-529
36. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., and Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20 (2000) 6309-6316
37. Komura J., and Sakamoto M. Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: long-term oral administration of several manganese compounds. Environ. Res. 57 (1992) 34-44
38. Langeveld C.H., Schepens E., Jongenelen C.A., Stoof J.C., Hjelle O.P., Ottersen O.P., and Drukarch B. Presence of glutathione immunoreactivity in cultured neurons and astrocytes. Neuroreport 7 (1996) 1833-1836
39. Lawson L.J., Perry V.H., Dri P., and Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 (1990) 151-170
40. Liu B. Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J. 8 (2006) 606-621
41. Liu B., Wang K., Gao H.M., Mandavilli B., Wang J.Y., and Hong J.S. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J. Neurochem. 77 (2001) 182-189
42. Liu B., Gao H.M., and Hong J.S. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 8 (2003) 1065-1073
43. 2 generation during neuromelanin synthesis. The action of manganese. Acta Med. Port. 6 (1993) 547-554
44. Martin C.J. Manganese neurotoxicity: connecting the dots along the continuum of dysfunction. Neurotoxicology 27 (2006) 347-349
45. Martins Chaves M., Caldeira Costa D., Costa Telhado Pereira C., Andrade T.R., Horta B.C., and Nogueira-Machado J.A. Role of inositol 1,4,5-triphosphate and p38 mitogen-activated protein kinase in reactive oxygen species generation by granulocytes in a cyclic AMP-dependent manner: an age-related phenomenon. Gerontology 53 (2007) 228-233
46. McCubrey J.A., Lahair M.M., and Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal 8 (2006) 1775-1789
47. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10 (2004) S3-S7
48. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann. N.Y. Acad. Sci. 1012 (2004) 209-223
49. Racette B.A., McGee-Minnich L., Moerlein S.M., Mink J.W., Videen T.O., and Perlmutter J.S. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 56 (2001) 8-13
50. Racette B.A., Tabbal S.D., Jennings D., Good L., Perlmutter J.S., and Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 64 (2005) 230-235
51. Rezvani H.R., Dedieu S., North S., Belloc F., Rossignol R., Letellier T., de Verneuil H., Taieb A., and Mazurier F. Hypoxia-inducible factor-1{alpha}, a key factor in the keratinocyte response to UVB exposure. J. Biol. Chem. 282 (2007) 16413-16422
52. Shi X.L., and Dalal N.S. The glutathionyl radical formation in the reaction between manganese and glutathione and its neurotoxic implications. Med. Hypotheses 33 (1990) 83-87
53. Stokes A.H., Lewis D.Y., Lash L.H., Jerome W.G., Grant K.W., Aschner M., and Vrana K.E. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis. Brain Res. 858 (2000) 1-8
54. Stolk J., Hiltermann T.J., Dijkman J.H., and Verhoeven A.J. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 11 (1994) 95-102
55. Stredrick D.L., Stokes A.H., Worst T.J., Freeman W.M., Johnson E.A., Lash L.H., Aschner M., and Vrana K.E. Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology 25 (2004) 543-553
56. Sun X., Shih A.Y., Johannssen H.C., Erb H., Li P., and Murphy T.H. Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. J. Biol. Chem. 281 (2006) 17420-17431
57. Tan E.K., Tan C., Fook-Chong S.M., Lum S.Y., Chai A., Chung H., Shen H., Zhao Y., Teoh M.L., Yih Y., Pavanni R., Chandran V.R., and Wong M.C. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J. Neurol. Sci. 216 (2003) 163-167
58. Tiffany-Castiglion E., and Qian Y. Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 22 (2001) 577-592
59. Vila M., Jackson-Lewis V., Guegan C., Wu D.C., Teismann P., Choi D.K., Tieu K., and Przedborski S. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14 (2001) 483-489
60. Wang T., Qin L., Liu B., Liu Y., Wilson B., Eling T.E., Langenbach R., Taniura S., and Hong J.S. Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J. Neurochem. 88 (2004) 939-947
61. Zhang P., Wang Y.Z., Kagan E., and Bonner J.C. Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J. Biol. Chem. 275 (2000) 22479-22486
62. Zhou M., Diwu Z., Panchuk-Voloshina N., and Haugland R.P. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal. Biochem. 253 (1997) 162-168